Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens

Biological Research

Volumn 43, Issue 3, 2010, Pages 287-289

  Toledo, Víctor ^a   Ramírez, Galia ^a   Valck, Carolina ^a   López, Nandy ^a   Ribeiro, Carolina H ^a   Maldonado, Ismael ^a   Aguilar, Lorena ^a   Lemus, David ^a   Ferreira, Arturo ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Anti angiogenesis; Calreticulin; T. cruzi

Indexed keywords

HOMO SAPIENS; TRYPANOSOMA CRUZI;

EID: 78650053837     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602010000300004     Document Type: Article

References (22)

1. AGUILAR L, RAMÍREZ G, VALCK C, MOLINA MC, ROJAS A, SCHWAEBLE W, FERREIRA V and FERREIRA A (2005) F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement. Biol Res 38, 187-95.
2. AGUILLON JC, FERREIRA L, PÉREZ C, COLOMBO A, MOLINA MC, WALLACE A, SOLARI A, CARVALLO P, GALINDO M, GALANTI N, ORN A, BILLETTA R and FERREIRA A (2000) Tc45, a dimorphic Trypanosoma cruzi immunogen with variable chromosomal localization, is calreticulin. Am J Trop Med Hyg 63, 306-12.
3. BASTIEN JW (1998) The Kiss of Death: Chagas Disease in the Americas. University of Utah Press, Salt Lake City.
4. CHENG WF, HUNG CF, CHAI CY, HSU KF, HE L, LING M and WU TC (2001) Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 108, 669-78.
5. FERREIRA V, VALCK C, SÁNCHEZ G, GINGRAS A, TZIMA S, MOLINA MC, SIM R, SCHWAEBLE W and FERREIRA A (2004) The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. J Immunol 172, 3042-50.
6. FRASER SA, KARIMI R, MICHALAK M and HUDIG D (2000) Perforin lytic activity is controlled by calreticulin. J Immunol 164, 4150-5.
7. GALLIARD H, BRUMPT L and MARTÍNEZ R (1950) Infections Expérimentales a Trypanosoma cruzi Chagas chez l' homme a propos de la biotherapie du cancer. Bull Soc Path Exot 43, 204-216.
8. KIERSZENBAUM F (2005) Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol 21, 513-6.
9. LEMUS D, DABANCENS A, ILLANES J, FUENZALIDA M, GUERRERO A and LÓPEZ C (2001) Antiangiogenic effect of betamethasone on the chick cam stimulated by TA3 tumor supernatant. Biol Res 34, 227-36.
10. LÓPEZ N, VALCK C, RAMÍREZ G, RODRÍGUEZ M, RIBEIRO CH, ORELLANA J, MALDONADO I, ALBINI A, ANACONA D, LEMUS D, AGUILAR L, SCHWAEBLE W and FERREIRA A (2010) Antiangiogenic and Antitumor Effects of Trypanosoma cruzi Calreticulin. PLoS Negl Trop Dis In Press.
11. MICHALAK M, CORBETT EF, MESAELI N, NAKAMURA K and OPAS M (1999) Calreticulin: one protein, one gene, many functions. Biochem J 344 Pt 2, 281-92.
12. MICHALAK M, MILNER RE, BURNS K and OPAS M (1992) Calreticulin. Biochem J 285 (Pt 3), 681-92.
13. OLIVEIRA EC, LEITE M. S, MIRANDA JA, ANDRADE AL, GARCÍA SB, LUQUETTI A O and MOREIRA H (2001) Chronic Trypanosoma cruzi infection associated with low incidence of 1,2-dimethylhydrazineinduced colon cancer in rats. Carcinogenesis 22, 737-40.
14. OSTWALD TJ and MACLENNAN DH (1974) Isolation of a high affinity calcium-binding protein from sarcoplasmic reticulum. J Biol Chem 249, 974-9.
15. PIKE SE, YAO L, JONES KD, CHERNEY B, APPELLA E, SAKAGUCHI K, NAKHASI H, TERUYA-FELDSTEIN J, WIRTH P, GUPTA G and TOSATO G (1998) Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med 188, 2349-56.
16. PIKE SE, YAO L, SETSUDA J, JONES KD, CHERNEY B, APPELLA E, SAKAGUCHI K, NAKHASI H, ATREYA CD, TERUYA-FELDSTEIN J, WIRTH P, GUPTA G and TOSATO G (1999) Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 94, 2461-8.
17. PINEDO HM, VERHEUL HM, D'AMATO RJ and FOLKMAN J (1998) Involvement of platelets in tumour angiogenesis? Lancet 352, 1775-7.
18. RAMÍREZ G, VALCK C, MOLINA MC, RIBEIRO CH, LOPEZ N, SANCHEZ G, FERREIRA VP, BILLETTA R, AGUILAR L, MALDONADO I, CATTAN P, SCHWAEBLE W and FERREIRA A (2010) Trypanosoma cruzi calreticulin: A novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity. Immunobiology In Press.
19. ROSKIN G (1946) Toxin therapy of experimental cancer; the influence of protozoan infections upon transplanted cancer. Am Rev Sov Med 4, 111-5.
20. TEIXEIRA MM, GAZZINELLI RT and SILVA JS (2002) Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 18, 262-5.
21. VALCK C, RAMÍREZ G, LÓPEZ N, RIBEIRO CH, MALDONADO I, SANCHEZ G, FERREIRA VP, SCHWAEBLE W and FERREIRA A (2010) Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin. Mol Immunol 47, 1516-21.
22. ZETTER BR (1998) Angiogenesis and tumor metastasis. Annu Rev Med 49, 407-24.